1 Study Coverage
    1.1 Atypical Antipsychotic Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Atypical Antipsychotic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Risperidone
        1.2.3 Olanzapine
        1.2.4 Quetiapine
        1.2.5 Ziprasidone
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Atypical Antipsychotic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Bipolar I Disorder
        1.3.3 Schizophrenia
        1.3.4 Schizoaffective Disorder
        1.3.5 Major Depressive Disorder (MDD)
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Atypical Antipsychotic Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Atypical Antipsychotic Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Atypical Antipsychotic Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Atypical Antipsychotic Drugs Sales by Region
        2.4.1 Global Atypical Antipsychotic Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Atypical Antipsychotic Drugs by Region (2023-2028)
    2.5 Global Atypical Antipsychotic Drugs Revenue by Region
        2.5.1 Global Atypical Antipsychotic Drugs Revenue by Region (2017-2022)
        2.5.2 Global Atypical Antipsychotic Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Atypical Antipsychotic Drugs Sales by Manufacturers
        3.1.1 Global Top Atypical Antipsychotic Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Atypical Antipsychotic Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Atypical Antipsychotic Drugs in 2021
    3.2 Global Atypical Antipsychotic Drugs Revenue by Manufacturers
        3.2.1 Global Atypical Antipsychotic Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Atypical Antipsychotic Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Atypical Antipsychotic Drugs Revenue in 2021
    3.3 Global Atypical Antipsychotic Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Atypical Antipsychotic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Atypical Antipsychotic Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Atypical Antipsychotic Drugs Sales by Type
        4.1.1 Global Atypical Antipsychotic Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Atypical Antipsychotic Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Atypical Antipsychotic Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Atypical Antipsychotic Drugs Revenue by Type
        4.2.1 Global Atypical Antipsychotic Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Atypical Antipsychotic Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Atypical Antipsychotic Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Atypical Antipsychotic Drugs Price by Type
        4.3.1 Global Atypical Antipsychotic Drugs Price by Type (2017-2022)
        4.3.2 Global Atypical Antipsychotic Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Atypical Antipsychotic Drugs Sales by Application
        5.1.1 Global Atypical Antipsychotic Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Atypical Antipsychotic Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Atypical Antipsychotic Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Atypical Antipsychotic Drugs Revenue by Application
        5.2.1 Global Atypical Antipsychotic Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Atypical Antipsychotic Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Atypical Antipsychotic Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Atypical Antipsychotic Drugs Price by Application
        5.3.1 Global Atypical Antipsychotic Drugs Price by Application (2017-2022)
        5.3.2 Global Atypical Antipsychotic Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Atypical Antipsychotic Drugs Market Size by Type
        6.1.1 North America Atypical Antipsychotic Drugs Sales by Type (2017-2028)
        6.1.2 North America Atypical Antipsychotic Drugs Revenue by Type (2017-2028)
    6.2 North America Atypical Antipsychotic Drugs Market Size by Application
        6.2.1 North America Atypical Antipsychotic Drugs Sales by Application (2017-2028)
        6.2.2 North America Atypical Antipsychotic Drugs Revenue by Application (2017-2028)
    6.3 North America Atypical Antipsychotic Drugs Market Size by Country
        6.3.1 North America Atypical Antipsychotic Drugs Sales by Country (2017-2028)
        6.3.2 North America Atypical Antipsychotic Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Atypical Antipsychotic Drugs Market Size by Type
        7.1.1 Europe Atypical Antipsychotic Drugs Sales by Type (2017-2028)
        7.1.2 Europe Atypical Antipsychotic Drugs Revenue by Type (2017-2028)
    7.2 Europe Atypical Antipsychotic Drugs Market Size by Application
        7.2.1 Europe Atypical Antipsychotic Drugs Sales by Application (2017-2028)
        7.2.2 Europe Atypical Antipsychotic Drugs Revenue by Application (2017-2028)
    7.3 Europe Atypical Antipsychotic Drugs Market Size by Country
        7.3.1 Europe Atypical Antipsychotic Drugs Sales by Country (2017-2028)
        7.3.2 Europe Atypical Antipsychotic Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Atypical Antipsychotic Drugs Market Size by Type
        8.1.1 Asia Pacific Atypical Antipsychotic Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Atypical Antipsychotic Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Atypical Antipsychotic Drugs Market Size by Application
        8.2.1 Asia Pacific Atypical Antipsychotic Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Atypical Antipsychotic Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Atypical Antipsychotic Drugs Market Size by Region
        8.3.1 Asia Pacific Atypical Antipsychotic Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Atypical Antipsychotic Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Atypical Antipsychotic Drugs Market Size by Type
        9.1.1 Latin America Atypical Antipsychotic Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Atypical Antipsychotic Drugs Revenue by Type (2017-2028)
    9.2 Latin America Atypical Antipsychotic Drugs Market Size by Application
        9.2.1 Latin America Atypical Antipsychotic Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Atypical Antipsychotic Drugs Revenue by Application (2017-2028)
    9.3 Latin America Atypical Antipsychotic Drugs Market Size by Country
        9.3.1 Latin America Atypical Antipsychotic Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Atypical Antipsychotic Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Atypical Antipsychotic Drugs Market Size by Type
        10.1.1 Middle East and Africa Atypical Antipsychotic Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Atypical Antipsychotic Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Atypical Antipsychotic Drugs Market Size by Application
        10.2.1 Middle East and Africa Atypical Antipsychotic Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Atypical Antipsychotic Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Atypical Antipsychotic Drugs Market Size by Country
        10.3.1 Middle East and Africa Atypical Antipsychotic Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Atypical Antipsychotic Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Novartis AG
        11.1.1 Novartis AG Corporation Information
        11.1.2 Novartis AG Overview
        11.1.3 Novartis AG Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Novartis AG Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Novartis AG Recent Developments
    11.2 Cardinal Health
        11.2.1 Cardinal Health Corporation Information
        11.2.2 Cardinal Health Overview
        11.2.3 Cardinal Health Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Cardinal Health Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Cardinal Health Recent Developments
    11.3 Johnson and Johnson
        11.3.1 Johnson and Johnson Corporation Information
        11.3.2 Johnson and Johnson Overview
        11.3.3 Johnson and Johnson Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Johnson and Johnson Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Johnson and Johnson Recent Developments
    11.4 Allergan
        11.4.1 Allergan Corporation Information
        11.4.2 Allergan Overview
        11.4.3 Allergan Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Allergan Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Allergan Recent Developments
    11.5 Sanis Health
        11.5.1 Sanis Health Corporation Information
        11.5.2 Sanis Health Overview
        11.5.3 Sanis Health Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Sanis Health Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Sanis Health Recent Developments
    11.6 Pfizer
        11.6.1 Pfizer Corporation Information
        11.6.2 Pfizer Overview
        11.6.3 Pfizer Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Pfizer Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Pfizer Recent Developments
    11.7 GlaxoSmithKline
        11.7.1 GlaxoSmithKline Corporation Information
        11.7.2 GlaxoSmithKline Overview
        11.7.3 GlaxoSmithKline Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 GlaxoSmithKline Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 GlaxoSmithKline Recent Developments
    11.8 Bristol-Myers Squibb Company
        11.8.1 Bristol-Myers Squibb Company Corporation Information
        11.8.2 Bristol-Myers Squibb Company Overview
        11.8.3 Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Bristol-Myers Squibb Company Recent Developments
    11.9 Sun Pharmaceutical Industries
        11.9.1 Sun Pharmaceutical Industries Corporation Information
        11.9.2 Sun Pharmaceutical Industries Overview
        11.9.3 Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Sun Pharmaceutical Industries Recent Developments
    11.10 Eil Lilly and Company
        11.10.1 Eil Lilly and Company Corporation Information
        11.10.2 Eil Lilly and Company Overview
        11.10.3 Eil Lilly and Company Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Eil Lilly and Company Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Eil Lilly and Company Recent Developments
    11.11 AstraZeneca
        11.11.1 AstraZeneca Corporation Information
        11.11.2 AstraZeneca Overview
        11.11.3 AstraZeneca Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 AstraZeneca Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 AstraZeneca Recent Developments
    11.12 Sumitomo Dainippon Pharma
        11.12.1 Sumitomo Dainippon Pharma Corporation Information
        11.12.2 Sumitomo Dainippon Pharma Overview
        11.12.3 Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Sumitomo Dainippon Pharma Recent Developments
    11.13 Qilu Pharmaceutical
        11.13.1 Qilu Pharmaceutical Corporation Information
        11.13.2 Qilu Pharmaceutical Overview
        11.13.3 Qilu Pharmaceutical Atypical Antipsychotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Qilu Pharmaceutical Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Qilu Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Atypical Antipsychotic Drugs Industry Chain Analysis
    12.2 Atypical Antipsychotic Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Atypical Antipsychotic Drugs Production Mode & Process
    12.4 Atypical Antipsychotic Drugs Sales and Marketing
        12.4.1 Atypical Antipsychotic Drugs Sales Channels
        12.4.2 Atypical Antipsychotic Drugs Distributors
    12.5 Atypical Antipsychotic Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Atypical Antipsychotic Drugs Industry Trends
    13.2 Atypical Antipsychotic Drugs Market Drivers
    13.3 Atypical Antipsychotic Drugs Market Challenges
    13.4 Atypical Antipsychotic Drugs Market Restraints
14 Key Findings in The Global Atypical Antipsychotic Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Atypical Antipsychotic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Risperidone
    Table 3. Major Manufacturers of Olanzapine
    Table 4. Major Manufacturers of Quetiapine
    Table 5. Major Manufacturers of Ziprasidone
    Table 6. Major Manufacturers of Others
    Table 7. Global Atypical Antipsychotic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Atypical Antipsychotic Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Atypical Antipsychotic Drugs Sales by Region (2017-2022) & (K Units)
    Table 10. Global Atypical Antipsychotic Drugs Sales Market Share by Region (2017-2022)
    Table 11. Global Atypical Antipsychotic Drugs Sales by Region (2023-2028) & (K Units)
    Table 12. Global Atypical Antipsychotic Drugs Sales Market Share by Region (2023-2028)
    Table 13. Global Atypical Antipsychotic Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Atypical Antipsychotic Drugs Revenue Market Share by Region (2017-2022)
    Table 15. Global Atypical Antipsychotic Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Atypical Antipsychotic Drugs Revenue Market Share by Region (2023-2028)
    Table 17. Global Atypical Antipsychotic Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Atypical Antipsychotic Drugs Sales Share by Manufacturers (2017-2022)
    Table 19. Global Atypical Antipsychotic Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Atypical Antipsychotic Drugs Revenue Share by Manufacturers (2017-2022)
    Table 21. Atypical Antipsychotic Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global Atypical Antipsychotic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Atypical Antipsychotic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atypical Antipsychotic Drugs as of 2021)
    Table 24. Atypical Antipsychotic Drugs Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Atypical Antipsychotic Drugs Product Offered
    Table 26. Date of Manufacturers Enter into Atypical Antipsychotic Drugs Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Atypical Antipsychotic Drugs Sales by Type (2017-2022) & (K Units)
    Table 29. Global Atypical Antipsychotic Drugs Sales by Type (2023-2028) & (K Units)
    Table 30. Global Atypical Antipsychotic Drugs Sales Share by Type (2017-2022)
    Table 31. Global Atypical Antipsychotic Drugs Sales Share by Type (2023-2028)
    Table 32. Global Atypical Antipsychotic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Atypical Antipsychotic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Atypical Antipsychotic Drugs Revenue Share by Type (2017-2022)
    Table 35. Global Atypical Antipsychotic Drugs Revenue Share by Type (2023-2028)
    Table 36. Atypical Antipsychotic Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global Atypical Antipsychotic Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global Atypical Antipsychotic Drugs Sales by Application (2017-2022) & (K Units)
    Table 39. Global Atypical Antipsychotic Drugs Sales by Application (2023-2028) & (K Units)
    Table 40. Global Atypical Antipsychotic Drugs Sales Share by Application (2017-2022)
    Table 41. Global Atypical Antipsychotic Drugs Sales Share by Application (2023-2028)
    Table 42. Global Atypical Antipsychotic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Atypical Antipsychotic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Atypical Antipsychotic Drugs Revenue Share by Application (2017-2022)
    Table 45. Global Atypical Antipsychotic Drugs Revenue Share by Application (2023-2028)
    Table 46. Atypical Antipsychotic Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 47. Global Atypical Antipsychotic Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 48. North America Atypical Antipsychotic Drugs Sales by Type (2017-2022) & (K Units)
    Table 49. North America Atypical Antipsychotic Drugs Sales by Type (2023-2028) & (K Units)
    Table 50. North America Atypical Antipsychotic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Atypical Antipsychotic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Atypical Antipsychotic Drugs Sales by Application (2017-2022) & (K Units)
    Table 53. North America Atypical Antipsychotic Drugs Sales by Application (2023-2028) & (K Units)
    Table 54. North America Atypical Antipsychotic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Atypical Antipsychotic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Atypical Antipsychotic Drugs Sales by Country (2017-2022) & (K Units)
    Table 57. North America Atypical Antipsychotic Drugs Sales by Country (2023-2028) & (K Units)
    Table 58. North America Atypical Antipsychotic Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Atypical Antipsychotic Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Atypical Antipsychotic Drugs Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Atypical Antipsychotic Drugs Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Atypical Antipsychotic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Atypical Antipsychotic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Atypical Antipsychotic Drugs Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Atypical Antipsychotic Drugs Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Atypical Antipsychotic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Atypical Antipsychotic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Atypical Antipsychotic Drugs Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Atypical Antipsychotic Drugs Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Atypical Antipsychotic Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Atypical Antipsychotic Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Atypical Antipsychotic Drugs Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Atypical Antipsychotic Drugs Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Atypical Antipsychotic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Atypical Antipsychotic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Atypical Antipsychotic Drugs Sales by Application (2017-2022) & (K Units)
    Table 77. Asia Pacific Atypical Antipsychotic Drugs Sales by Application (2023-2028) & (K Units)
    Table 78. Asia Pacific Atypical Antipsychotic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Atypical Antipsychotic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Atypical Antipsychotic Drugs Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Atypical Antipsychotic Drugs Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Atypical Antipsychotic Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Atypical Antipsychotic Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Atypical Antipsychotic Drugs Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Atypical Antipsychotic Drugs Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Atypical Antipsychotic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Atypical Antipsychotic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Atypical Antipsychotic Drugs Sales by Application (2017-2022) & (K Units)
    Table 89. Latin America Atypical Antipsychotic Drugs Sales by Application (2023-2028) & (K Units)
    Table 90. Latin America Atypical Antipsychotic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Atypical Antipsychotic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Atypical Antipsychotic Drugs Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Atypical Antipsychotic Drugs Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Atypical Antipsychotic Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Atypical Antipsychotic Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Atypical Antipsychotic Drugs Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Atypical Antipsychotic Drugs Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Atypical Antipsychotic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Atypical Antipsychotic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Atypical Antipsychotic Drugs Sales by Application (2017-2022) & (K Units)
    Table 101. Middle East and Africa Atypical Antipsychotic Drugs Sales by Application (2023-2028) & (K Units)
    Table 102. Middle East and Africa Atypical Antipsychotic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Atypical Antipsychotic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Atypical Antipsychotic Drugs Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Atypical Antipsychotic Drugs Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Atypical Antipsychotic Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Atypical Antipsychotic Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Novartis AG Corporation Information
    Table 109. Novartis AG Description and Major Businesses
    Table 110. Novartis AG Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. Novartis AG Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Novartis AG Recent Developments
    Table 113. Cardinal Health Corporation Information
    Table 114. Cardinal Health Description and Major Businesses
    Table 115. Cardinal Health Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. Cardinal Health Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Cardinal Health Recent Developments
    Table 118. Johnson and Johnson Corporation Information
    Table 119. Johnson and Johnson Description and Major Businesses
    Table 120. Johnson and Johnson Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. Johnson and Johnson Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Johnson and Johnson Recent Developments
    Table 123. Allergan Corporation Information
    Table 124. Allergan Description and Major Businesses
    Table 125. Allergan Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. Allergan Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Allergan Recent Developments
    Table 128. Sanis Health Corporation Information
    Table 129. Sanis Health Description and Major Businesses
    Table 130. Sanis Health Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 131. Sanis Health Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Sanis Health Recent Developments
    Table 133. Pfizer Corporation Information
    Table 134. Pfizer Description and Major Businesses
    Table 135. Pfizer Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 136. Pfizer Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Pfizer Recent Developments
    Table 138. GlaxoSmithKline Corporation Information
    Table 139. GlaxoSmithKline Description and Major Businesses
    Table 140. GlaxoSmithKline Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 141. GlaxoSmithKline Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. GlaxoSmithKline Recent Developments
    Table 143. Bristol-Myers Squibb Company Corporation Information
    Table 144. Bristol-Myers Squibb Company Description and Major Businesses
    Table 145. Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 146. Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Bristol-Myers Squibb Company Recent Developments
    Table 148. Sun Pharmaceutical Industries Corporation Information
    Table 149. Sun Pharmaceutical Industries Description and Major Businesses
    Table 150. Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 151. Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Sun Pharmaceutical Industries Recent Developments
    Table 153. Eil Lilly and Company Corporation Information
    Table 154. Eil Lilly and Company Description and Major Businesses
    Table 155. Eil Lilly and Company Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 156. Eil Lilly and Company Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Eil Lilly and Company Recent Developments
    Table 158. AstraZeneca Corporation Information
    Table 159. AstraZeneca Description and Major Businesses
    Table 160. AstraZeneca Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 161. AstraZeneca Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. AstraZeneca Recent Developments
    Table 163. Sumitomo Dainippon Pharma Corporation Information
    Table 164. Sumitomo Dainippon Pharma Description and Major Businesses
    Table 165. Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 166. Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Sumitomo Dainippon Pharma Recent Developments
    Table 168. Qilu Pharmaceutical Corporation Information
    Table 169. Qilu Pharmaceutical Description and Major Businesses
    Table 170. Qilu Pharmaceutical Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 171. Qilu Pharmaceutical Atypical Antipsychotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Qilu Pharmaceutical Recent Developments
    Table 173. Key Raw Materials Lists
    Table 174. Raw Materials Key Suppliers Lists
    Table 175. Atypical Antipsychotic Drugs Distributors List
    Table 176. Atypical Antipsychotic Drugs Customers List
    Table 177. Atypical Antipsychotic Drugs Market Trends
    Table 178. Atypical Antipsychotic Drugs Market Drivers
    Table 179. Atypical Antipsychotic Drugs Market Challenges
    Table 180. Atypical Antipsychotic Drugs Market Restraints
    Table 181. Research Programs/Design for This Report
    Table 182. Key Data Information from Secondary Sources
    Table 183. Key Data Information from Primary Sources
List of Figures
    Figure 1. Atypical Antipsychotic Drugs Product Picture
    Figure 3. Global Atypical Antipsychotic Drugs Market Share by Type in 2021 & 2028
    Figure 3. Risperidone Product Picture
    Figure 4. Olanzapine Product Picture
    Figure 5. Quetiapine Product Picture
    Figure 6. Ziprasidone Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Atypical Antipsychotic Drugs Market Share by Application in 2021 & 2028
    Figure 9. Bipolar I Disorder
    Figure 10. Schizophrenia
    Figure 11. Schizoaffective Disorder
    Figure 12. Major Depressive Disorder (MDD)
    Figure 13. Atypical Antipsychotic Drugs Report Years Considered
    Figure 14. Global Atypical Antipsychotic Drugs Sales 2017-2028 (K Units)
    Figure 15. Global Atypical Antipsychotic Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Atypical Antipsychotic Drugs Revenue 2017-2028 (US$ Million)
    Figure 17. Global Atypical Antipsychotic Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Atypical Antipsychotic Drugs Sales Market Share by Region (2017-2022)
    Figure 19. Global Atypical Antipsychotic Drugs Sales Market Share by Region (2023-2028)
    Figure 20. North America Atypical Antipsychotic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 21. North America Atypical Antipsychotic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Atypical Antipsychotic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 23. Europe Atypical Antipsychotic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Atypical Antipsychotic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 25. Asia-Pacific Atypical Antipsychotic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Atypical Antipsychotic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 27. Latin America Atypical Antipsychotic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Atypical Antipsychotic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 29. Middle East & Africa Atypical Antipsychotic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Atypical Antipsychotic Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Atypical Antipsychotic Drugs in the World: Market Share by Atypical Antipsychotic Drugs Revenue in 2021
    Figure 32. Global Atypical Antipsychotic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Atypical Antipsychotic Drugs Sales Market Share by Type (2017-2028)
    Figure 34. Global Atypical Antipsychotic Drugs Revenue Market Share by Type (2017-2028)
    Figure 35. Global Atypical Antipsychotic Drugs Sales Market Share by Application (2017-2028)
    Figure 36. Global Atypical Antipsychotic Drugs Revenue Market Share by Application (2017-2028)
    Figure 37. North America Atypical Antipsychotic Drugs Sales Market Share by Type (2017-2028)
    Figure 38. North America Atypical Antipsychotic Drugs Revenue Market Share by Type (2017-2028)
    Figure 39. North America Atypical Antipsychotic Drugs Sales Market Share by Application (2017-2028)
    Figure 40. North America Atypical Antipsychotic Drugs Revenue Market Share by Application (2017-2028)
    Figure 41. North America Atypical Antipsychotic Drugs Sales Share by Country (2017-2028)
    Figure 42. North America Atypical Antipsychotic Drugs Revenue Share by Country (2017-2028)
    Figure 43. U.S. Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Atypical Antipsychotic Drugs Sales Market Share by Type (2017-2028)
    Figure 46. Europe Atypical Antipsychotic Drugs Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Atypical Antipsychotic Drugs Sales Market Share by Application (2017-2028)
    Figure 48. Europe Atypical Antipsychotic Drugs Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Atypical Antipsychotic Drugs Sales Share by Country (2017-2028)
    Figure 50. Europe Atypical Antipsychotic Drugs Revenue Share by Country (2017-2028)
    Figure 51. Germany Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. France Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Atypical Antipsychotic Drugs Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Atypical Antipsychotic Drugs Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Atypical Antipsychotic Drugs Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Atypical Antipsychotic Drugs Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Atypical Antipsychotic Drugs Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Atypical Antipsychotic Drugs Revenue Share by Region (2017-2028)
    Figure 62. China Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. India Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Atypical Antipsychotic Drugs Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Atypical Antipsychotic Drugs Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Atypical Antipsychotic Drugs Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Atypical Antipsychotic Drugs Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Atypical Antipsychotic Drugs Sales Share by Country (2017-2028)
    Figure 77. Latin America Atypical Antipsychotic Drugs Revenue Share by Country (2017-2028)
    Figure 78. Mexico Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Atypical Antipsychotic Drugs Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Atypical Antipsychotic Drugs Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Atypical Antipsychotic Drugs Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Atypical Antipsychotic Drugs Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Atypical Antipsychotic Drugs Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Atypical Antipsychotic Drugs Revenue Share by Country (2017-2028)
    Figure 87. Turkey Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 89. U.A.E Atypical Antipsychotic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 90. Atypical Antipsychotic Drugs Value Chain
    Figure 91. Atypical Antipsychotic Drugs Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed